AI-generated summary
The authors studied murine melanoma cells treated with pheophorbide a and light (photodynamic therapy) to examine why some cells recover after low-dose treatment. They report that low-dose treatment increased NF-κB and Snail while reducing RKIP, and that a NF-κB inhibitor acting as a nitric oxide donor shifted these markers toward a pattern seen with high-dose treatment. The findings come from cell experiments only, not from patients or animals.
- Who or what was studied
- B78-H1 murine amelanotic melanoma cells
- Limits stated in the abstract
- The study uses cultured cells only, so the results may not apply to tumors in people.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Dose, Reactive oxygen species, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.